The mission of the National Multiple Sclerosis Society is to end the devastating effects of MS Companies Release Results of Completed 2-Year Trial of Tysabri in MS Crohn's DiseaseLymphomaMultiple MyelomaMultiple SclerosisPsoriasisRheumatoid ArthritisOther and health insurance including news about Tysabri, reimbursement strategies and more Crohn's DiseaseLymphomaMultiple MyelomaMultiple SclerosisPsoriasisRheumatoid ArthritisOther and health insurance including news about Tysabri, reimbursement strategies and more Multiple Sclerosis Spotlight. FDA Approves TysabriŽ. Is It MS or Am I Going Crazy Impact of Winter Temperatures on Multiple Sclerosis. Living With Illness, Sometimes Two 942 patients with relapsing-remitting multiple sclerosis (RRMS), natalizumab reduced the rate of relapsing forms of multiple sclerosis (MS). FDA approval of TYSABRI comes more than 942 patients with relapsing-remitting multiple sclerosis (RRMS), natalizumab reduced the rate of relapsing forms of multiple sclerosis (MS). FDA approval of TYSABRI comes more than